FC
Fulcrum Capital’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Hold |
2,566
| – | – | 0.1% | 66 |
|
|
2025
Q1 | $538K | Buy |
2,566
+587
| +30% | +$123K | 0.12% | 58 |
|
|
2024
Q4 | $352K | Hold |
1,979
| – | – | 0.07% | 87 |
|
|
2024
Q3 | $391K | Hold |
1,979
| – | – | 0.09% | 79 |
|
|
2024
Q2 | $339K | Hold |
1,979
| – | – | 0.08% | 81 |
|
|
2024
Q1 | $360K | Hold |
1,979
| – | – | 0.09% | 79 |
|
|
2023
Q4 | $307K | Hold |
1,979
| – | – | 0.08% | 90 |
|
|
2023
Q3 | $295K | Hold |
1,979
| – | – | 0.09% | 82 |
|
|
2023
Q2 | $267K | Sell |
1,979
-525
| -21% | -$70.7K | 0.07% | 97 |
|
|
2023
Q1 | $399K | Buy |
2,504
+987
| +65% | +$157K | 0.11% | 75 |
|
|
2022
Q4 | $245K | Hold |
1,517
| – | – | 0.07% | 93 |
|
|
2022
Q3 | $204K | Buy |
1,517
+100
| +7% | +$13.4K | 0.06% | 78 |
|
|
2022
Q2 | $217K | Buy |
+1,417
| New | +$217K | 0.07% | 70 |
|
|
2021
Q3 | – | Sell |
-3,555
| Closed | -$400K | – | 89 |
|
|
2021
Q2 | $400K | Sell |
3,555
-799
| -18% | -$89.9K | 0.1% | 59 |
|
|
2021
Q1 | $471K | Sell |
4,354
-254
| -6% | -$27.5K | 0.14% | 56 |
|
|
2020
Q4 | $494K | Buy |
+4,608
| New | +$494K | 0.15% | 52 |
|
|
2020
Q3 | – | Sell |
-2,282
| Closed | -$224K | – | 62 |
|
|
2020
Q2 | $224K | Buy |
+2,282
| New | +$224K | 0.08% | 64 |
|
|
2020
Q1 | – | Sell |
-2,282
| Closed | -$202K | – | 63 |
|
|
2019
Q4 | $202K | Buy |
+2,282
| New | +$202K | 0.06% | 73 |
|
|
2019
Q2 | – | Sell |
-2,896
| Closed | -$233K | – | 61 |
|
|
2019
Q1 | $233K | Buy |
+2,896
| New | +$233K | 0.09% | 58 |
|